September 30, 2024
RIO DE JANEIRO — The addition of daratumumab to lenalidomide maintenance therapy following autologous stem cell transplant (ASCT) significantly improves rates of achieving minimal residual disease […]
September 30, 2024
The global withdrawal of voxelotor (Oxbryta, Pfizer) has left clinicians who treat sickle cell disease (SCD) with the urgent task of reaching patients taking the medicine, […]
September 27, 2024
TOPLINE: Omitting the 5-fluorouracil (5-FU) bolus from multidrug regimens in patients with advanced gastrointestinal cancers reduces toxicities, such as cytopenia, and does not affect overall survival. […]
September 27, 2024
TOPLINE: In patients with extramedullary plasmacytoma of the head and neck, radiotherapy and surgery provide comparable survival outcomes, but radiotherapy significantly reduced the risk for progression […]
September 26, 2024
Guinea pigs are important to Ohio State University leukemia specialist Kerry A. Rogers, MD, but not because they’re in her research laboratory, where the focus is […]
September 26, 2024
TOPLINE: Patients with stage I non–small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) have a low rate of acute toxicities and 90-day mortality, […]
September 26, 2024
The monthly cost of treating disease is not associated with a patient with breast cancer surviving or the disease worsening, according to new research. A key […]
September 26, 2024
BARCELONA, Spain — A trial conducted across 40 Italian centers has underscored the significance of a new mutational approach to cancer research. The Rome Study, presented […]
September 26, 2024
Providing genetic testing for BRCA1 and BRCA2 mutations in all women aged 30 years or older would be cost-effective and prevent more breast and ovarian cancers […]